Poseida Therapeutics/ Inc. – Talk Bio

Actionable Insights Powered by AI

From Partnership to Acquisition: The $1.5 Billion Journey of Roche and Poseida Therapeutics

4 months ago talkbio0Tagged Acquisition, allogeneic cell therapy, biotech, CAR-T, Drug Industry, Genetic, genetic medicines, Poseida Therapeutics/ Inc., Roche (company)

Roche Holdings/ Inc., Poseida Therapeutics/ Inc., Allogeneic cell therapy, CAR-T programs, Genetic medicines, Biotech acquisition, Pharmaceutical industry